Leverage • 20/20 Biolabs
AIDX
20/20 Biolabs, Inc., based in Rockville, Maryland, is a commercial-stage diagnostics company dedicated to improving health outcomes through early disease detection. The company leverages machine learning and advanced laboratory techniques to develop innovative testing solutions. Its primary focus is on its 'OneTest' platform, a multi-cancer screening tool that analyzes a panel of tumor biomarkers to help identify the risk of several types of cancer in their early, more treatable stages. In addition to cancer diagnostics, 20/20 Biolabs has expanded its portfolio to include rapid diagnostic tests and laboratory services, notably providing COVID-19 testing solutions and other respiratory panels. The company operates a CLIA-certified and CAP-accredited laboratory, ensuring high standards for its diagnostic offerings. By combining biological data with artificial intelligence, 20/20 Biolabs aims to provide clinicians and patients with actionable health insights, positioning itself at the intersection of biotechnology and digital health. The company's mission is to make early cancer detection more accessible and effective through the integration of data science and clinical diagnostics.
0,9
N.D./EBITDA
How many years of EBITDA are required to pay off the company's net debt, according to the official accounting standard IFRS16. As a market consensus, a value of up to 3 years of leverage is accepted for most companies.
0%
Debt/Equity
How much the company's debt represents in % in relation to its equity. As a market consensus, a value less than or equal to 1 is accepted, above that leverage can end up hurting the final result at some point.
1,8
Current Ratio
The current ratio helps investors understand more about a company's ability to cover its short-term debt with its current assets and make apples-to-apples comparisons with its competitors and peers.
1,7
Quick Ratio
The quick ratio measures a company's capacity to pay its current liabilities without needing to sell its inventory or obtain additional financing and is considered a more conservative measure than the current ratio, which includes all current assets as coverage for current liabilities.
—
Interest Coverage
The interest coverage ratio is used to measure how well a firm can pay the interest due on outstanding debt and is is calculated by dividing a company's earnings before interest and taxes (EBIT) by its interest expense during a given period. Generally, a higher coverage ratio is better, although the ideal ratio may vary by industry.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!